Medicine Carton & Folding Box — Material Selection Guide

Why Board Grade Selection in Medicine Cartons Fails at the Spec Stage #

Pharmaceutical folding carton failures tend to cluster at two points: incoming QC rejection and end-user cartoning line jams. Both trace back to decisions made weeks earlier during board grade selection — or more accurately, during the absence of a structured selection process.

The symptoms are recognizable. A carton runs cleanly on your sample cartoning machine but jams at 180 cycles per minute on the client’s Uhlmann or Dividella line. A blister pack carton passes burst strength on arrival but deforms under the 60% RH warehouse conditions in Southeast Asian distribution. The tuck flap loses its spring after 90 days on shelf and no longer provides audible tamper evidence. A screen-printed Braille cell compresses past legibility within the first 12 months because the caliper wasn’t specified with the coating weight factored in.

Each symptom maps to a different material decision. The diagnostic table below is what we use in our CPG-011 brief intake form when a new medicine carton project comes in:

The Root Cause Most Specification Reviews Miss: Caliper vs. Basis Weight Confusion #

The single most misdiagnosed material problem we encounter in medicine carton briefs is treating basis weight (g/m²) and caliper (µm) as interchangeable specifications. They are not — and conflating them causes a chain of downstream failures that can take three sample iterations to diagnose correctly.

Here is the mechanism. SBS (Solid Bleached Sulfate) and FBB (Folding Box Board) at the same nominal basis weight — say 280 g/m² — can have calipers that differ by 80–120 µm depending on the furnish, formation, and calendering intensity. FBB achieves its stiffness-to-weight ratio through a layered construction: a mechanical pulp core sandwiched between bleached chemical pulp plies. This gives it higher bulk (lower density) at equivalent weight. SBS is a single-ply chemical pulp sheet, more uniform in cross-section, higher density, lower bulk.

For a standard 60 × 40 mm blister carton, this difference is critical. The same 280 g/m² FBB might caliper at 370–390 µm, while SBS at the same weight calipers at 290–310 µm. The thicker FBB panel will run with better lane separation on a leaflet insertion module. The thinner SBS panel may require guide rail adjustment or causes misfeed flags on the Bosch CUK carton erector at speeds above 160 cpm.

Now add the Braille requirement. ISO 11560 and the European Pharmacopoeia Braille specification both require embossed dots to be legible by touch, with dot height typically ≥0.2 mm above the panel surface. When the base board caliper is below 320 µm, the embossing die pushes through the coating layer and into the board’s top ply, which can crush the fiber structure and cause the dot to relax by 30–40% within 6 months. We confirm this with a dial depth gauge measurement immediately after embossing, then re-measure the same sample at 90 days under ambient warehouse conditions (23°C, 50% RH per ISO 187).

The confirmation threshold: if dot height relaxation exceeds 0.05 mm between day 0 and day 90, we flag the board grade as unsuitable and specify a move to minimum 350 µm caliper — regardless of the basis weight on the datasheet.

This matters more for cartons with both Braille and a child-resistant re-entry tuck lock, because the lock tab geometry depends on the board spring-back force, which is itself a function of caliper and MD stiffness together. At 280 µm caliper and Taber stiffness below 14 mN·m in the cross-direction, the lock tab doesn’t return reliably — and that’s a regulatory compliance issue in EU and UK markets under the Falsified Medicines Directive (EU 2011/62/EC).

Corrective Actions, Ranked by Impact and Turnaround Time #

1. Specify caliper range, not just basis weight, on every PO. Require 320–400 µm for standard blister cartons with Braille; 280–320 µm for plain-panel cartons without embossing or lock features. This costs nothing to add and eliminates the most common incoming QC dispute. The board mill datasheet will not default to this — you have to ask for it.

2. Add a Cobb 60 requirement for any carton going into humid distribution. Per ISO 535, Cobb 60 values below 20 g/m² on the print face indicate adequate internal sizing for 60–80% RH environments. SBS from most major European and Chinese mills runs at 12–18 g/m² on the coated face. Generic offset-grade board often runs at 25–35 g/m², which is insufficient. This check at incoming QC catches roughly two-thirds of humidity-deformation complaints before the carton ever reaches the cartoning line.

3. Specify grain direction relative to the cartoning line feed direction. Machine-direction grain should run parallel to the carton’s height dimension (the direction of travel through the carton erector). Cross-direction board causes score cracking on the bottom tuck panel. This is a zero-cost spec change with an outsized effect on line yield.

4. Re-evaluate board grade if the product distribution chain includes more than one ambient climate zone. A carton specified for EU ambient storage (15–25°C, 45–65% RH) will behave differently in Southeast Asian distribution (30–35°C, 70–90% RH). For multi-region SKUs, we typically specify SBS with 2-side PE-free barrier coating rather than relying on board sizing alone. This adds approximately 8–12% to board cost but eliminates reformulation requests after field complaints.

5. Run a trial on the actual cartoning line speed and carton geometry before releasing tooling. A sample that passes all material specs can still fail on a specific carton erector model due to glue-flap geometry or panel scoring sequence. Our standard pre-production protocol (logged internally as PVT-04) requires a 500-unit trial run at full production speed before first-article approval. Skipping this step is the primary reason first production batches generate jam-related downtime complaints.

What to Specify Upfront to Prevent These Failures #

When developing the PO and supplier brief for a medicine carton, include these explicit parameters to avoid sample iteration:

• Board grade: SBS or FBB (not interchangeable — state explicitly)
• Caliper range in µm (not just g/m² basis weight)
• Grain direction relative to carton height
• Cobb 60 maximum (recommend ≤20 g/m² on print face per ISO 535)
• Braille requirement: yes/no — if yes, specify minimum dot height (≥0.2 mm per ISO 11560)
• Child-resistant feature type: simple tuck, re-entry lock, or push-through
• Cartoning line model and speed (cpm) — your contract manufacturer should supply this
• Distribution climate: controlled ambient only, or includes tropical/humid zones

Request the board mill’s Technical Data Sheet (TDS) and ask for Taber stiffness values in both MD and CD, not just the average. A board spec without directional stiffness data is incomplete for pharmaceutical cartoning applications.

Specification Notes for Brand Partners #

When you brief us on a medicine carton project, the two pieces of information that most affect our material recommendation are the cartoning line model (or cpm target) and whether the product ships to humid climate zones. Both determine caliper and board grade before anything else on the brief.

The most common gap we see in initial briefs is an absence of distribution climate data. A client specifies SBS 275 g/m² because it matches their EU SKU, then asks why the carton wrinkles in their Singapore 3PL. The answer is almost always Cobb value and internal sizing — neither of which is visible in the board name or basis weight alone.

Our standard sampling timeline for a medicine carton with Braille and child-resistant features is 18–22 working days from approved dieline and confirmed board grade. Board grade changes after first sample approval typically add 10–14 working days. The document to request before signing off on a board specification is the board mill’s full TDS including Cobb 60, Taber stiffness (MD and CD), and caliper tolerance range. Without it, the specification is incomplete.

FAQ #

Why does the same g/m² board perform differently on different cartoning lines?
Basis weight alone doesn’t control the board’s physical behavior on a cartoning line — caliper, Taber stiffness, and moisture content all contribute. Two boards at 280 g/m² can differ by up to 100 µm in caliper depending on the furnish and calendering, and that difference directly affects how the carton blank feeds, erects, and closes at speeds above 150 cpm.

Does FBB always cost less than SBS for the same weight?
It depends on the application. FBB offers better bulk-to-weight ratio, which is useful for achieving higher caliper at lower basis weight — that can reduce material cost per carton. But for applications requiring high whiteness on both sides (inner pack printing, serialization codes on the inside panel), SBS is typically the better match regardless of cost delta, because FBB’s mechanical pulp core shows through on the uncoated inner face.

If our carton passes the sample approval, why would it fail at full production speed?
Sample runs are typically done at 20–50% of production speed, which reduces the mechanical stress on the carton blank during erection and tuck folding. At 160–200 cpm on a high-speed cartoner, flap spring-back timing and glue set speed both become critical. A carton that erects cleanly at 80 cpm can jam at 180 cpm if the board caliper is on the low end of specification. Our PVT-04 protocol runs the trial at the client’s stated target speed specifically to catch this gap.

Is SBS required for pharmaceutical cartons, or can we use recycled board?
Recycled board (CRB — Coated Recycled Board) is not suitable for primary pharmaceutical cartons under most regulatory frameworks. FDA 21 CFR and EU food/pharmaceutical contact regulations have specific restrictions on recycled fiber content due to potential migration of undesirable substances. For secondary pharmaceutical packaging not in direct product contact, CRB is sometimes used, but the fiber consistency and burst strength are lower — CRB typically runs 15–20% below SBS at equivalent basis weight in Mullen burst tests per TAPPI T 807. We do not specify CRB for any folding carton destined for prescription or OTC pharmaceutical applications.

Our carton needs to carry both a serialization code and a Braille panel on the same face. Is that a material compatibility issue?
Yes, and this is the one combination that requires explicit panel zoning in the structural design. The embossing die for Braille compresses the board surface locally. If the serialization 2D matrix code (DataMatrix per GS1 standards, with minimum X-dimension of 0.495 mm for pharmaceutical use) is positioned within 4 mm of an embossed Braille cell, the print registration shift from board deformation can push the code outside the ISO/IEC 16022 quiet zone tolerance, causing scanner read-failure. We specify a minimum 6 mm exclusion zone between Braille cell edges and any machine-readable code boundary.

What Taber stiffness values should we be specifying for a standard blister carton?
For a blister carton in the 55–80 mm height range running at 120–180 cpm, we specify minimum 18 mN·m in the machine direction and 12 mN·m in the cross direction per TAPPI T 489. Below these values, the side panel deflects under vacuum cup pick on the carton erector, causing a fold crease on the panel face. This is the most common cosmetic rejection at the client’s in-process QC that traces back to a board stiffness specification gap — not a printing or die-cutting problem.

---

Planning a packaging project? Contact our team to request a complimentary specification review and sample quote.

---